I'm interested in starting to use the minion for meso-throughput targeted sequencing (1.5-3kb amplicons). I haven't heard error rates for the R9 since just after they were released (Nick Loman's blog). What are people getting in the wild? If you can fully overlap the 2d reads, what's the consensus sequence error rate?
Unconfigured Ad
Collapse
X
-
Originally posted by thermophile View PostI'm interested in starting to use the minion for meso-throughput targeted sequencing (1.5-3kb amplicons). I haven't heard error rates for the R9 since just after they were released (Nick Loman's blog). What are people getting in the wild? If you can fully overlap the 2d reads, what's the consensus sequence error rate?
Good question. For 1D it is ~10-12% now, somewhat sample/sequence and alignment dependent. That would give you ~5-fold more data compared to 2D runs, but if you plan for barcoding and don't need the troughput 2D gives slightly lower error rates (can be ~3% but more often 6-10).
Consensus errors (from many reads) are mainly around short homopolymers but other sequences can show up as heterozygotes as well before polishing.
-
-
I checked error rates (bwa mem -x ont2d + picard CollectAlignmentSummary) for an amplicon run now, with 145 2D reads for a 8 kb human region. It gave 1.5% subst error and 3.2 % indel errors. This was reads from end of run, and with high coverage we can quality-filter reads if a lower average error rate is needed. Taking only the top 20% of reads (base qv > 25 on average) yields error rates of 0.66% for subst and 2.3 % for indels.Originally posted by thermophile View PostThanks. I'm afraid that's not good enough yet for what I want to do. But that's good to know.
Comment
-
-
taxonomic surveys-I generally want to look at many samples shallowly. I'm considering doing 16/18S + ITS1 to allow for the error rate but would need to do more bioinformatic pipeline writing than I currently have ability/time. I want to do this but think I'll push it to back burner for a few months till either the error rate drops or I have time/find a student to work on some processing pipeline that could leverage both ITS and 16s for clustering.Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.
Comment
-
-
Thanks Brian, I didn't mention that I'm trying to come up with a way to get longer reads that we can do inhouse and we don't have pacbio. I'm still waffling. It's cheap enough to try that I may give it a shot and try tempering my expectations.Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.
Comment
-
-
For taxonomic surveys, you'd be better off doing a full metagenomic analysis instead of looking at specific genes. The MinION is more than adequate for this purpose.
Metrichor provides a WIMP ("What's In My Pot") workflow for doing exactly this. It uses Kraken* behind the scenes to vote on the origin of subsequences of each read, generating a consensus taxon for each read. The end result is a tree with counts that will show in real time (i.e. during sequencing) the content of your sample. The output using extracted, unamplified DNA correlates extremely well with the expected output for "canned" metagenomic samples:
* it used to use Kraken, but that may have changed with recent releases
Comment
-
-
The error rate is also species-dependent. If I'm not mistaken the basecaller is mainly trained on the e.colli and lambda genome. Improvements to base calling for human genomes will happen if training is also applied to those genomes. (I believe this is being worked on).
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
-
by GATTACATLove this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
-
Channel: Articles
07-01-2026, 11:43 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
24 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
15 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
33 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
||
|
Started by SEQadmin2, 07-02-2026, 11:08 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-02-2026, 11:08 AM
|
Comment